跳至主要内容
临床试验/IRCT20120918010876N6
IRCT20120918010876N6已完成3 期

Comparison of two various aspirin dosage (80mg and 120mg daily) on prevention of pre-eclampsia in high risk pregnant women

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 729 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
729

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Pregnant women over 18 years of age
  • Gestational age of 12-20 weeks
  • High risk factors for pre-eclampsia (such as multiple pregnancy, chronic hypertension, diabetes mellitus type 1 or 2 , chronic kidney disease, autoimmune disease (antiphospholipid syndrome, lupus)
  • History of pre-eclampsia or bad outcomes in previous pregnancies
  • The presence of a viable fetus

排除标准

  • Existence of Cardiovascular, liver, thyroid, hemorrhagic or peptic ulcer diseases
  • History of asthma
  • Sensitivity to aspirin
  • Major fetal disorders
  • Prolonged use of NSAIDs

研究者

相似试验